Alto Neuroscience, Inc. (ANRO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Alto Neuroscience, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -8.12x | -1.69x | -15.33x | -19.10x | -57.62x |
| P/B Ratio | 3.40x | 0.69x | -7.76x | -13.78x | -42.43x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 2520.90x |
| Profitability | |||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 31.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | -5741.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | -4374.8% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | -4305.7% |
| Liquidity | |||||
| Current Ratio | 15.69x | 16.92x | 15.22x | 8.85x | 15.30x |
| Quick Ratio | 15.69x | 16.92x | 15.22x | 8.85x | 15.30x |
| Leverage | |||||
| Debt/Equity | 0.03x | 0.11x | -0.14x | -2.14x | -3.06x |
YoY = year-over-year change. Source: FMP..